Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Thomas Kuivila, MD, is Staff Physician, Pediatric Orthopaedic Surgery, Department of Orthopaedic Surgery at Cleveland Clinic. He is the Vice Chair for Education of the Orthopaedic & Rheumatologic Institute and is the Residency Program Director in Orthopaedic Surgery.
Dr. Kuivila’s special interests include congenital and developmental spinal disorders to include scoliosis, kyphosis and sponylolysis and lithesis. He is also an expert in pediatric orthopaedic traumatology. His research interests include bioabsorbable fixation and minimally invasive scoliosis surgery.
He did his orthopaedic surgery residency at Cleveland Clinic, served as an A-O international orthopaedic traumatology fellow in Graz, Austria and was a pediatric orthopaedic surgery fellow at Brown University and Rhode Island Hospital in Providence, R.I. Dr. Kuivila then spent six years in the United States Air Force Medical Corps. There, he served as Orthopaedic Department Chairman at Keesler U.S.A.F. Medical Center in Biloxi, Miss., and subsequently as the Chief of Pediatric Orthopaedic Surgery at Wilford Hall U.S.A.F. Medical Center in San Antonio, Tex.
While in San Antonio, he was also the U.S.A.F. residency program director in orthopaedic surgery and a consultant to the Air Force Surgeon General. Dr. Kuivila brings to the department considerable experience and expertise in the management of complex acquired and congenital pediatric and adolescent orthopaedic disorders of the spine and extremities.
CPediatric, Adolescent and Young Adult Spinal Surgery; Pediatric Orthopaedic Trauma and Post-Traumatic Deformity
Awards & Honors
Best Doctors in America, Pediatric Orthopaedic Surgery, 2003-2011
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Kuivila's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.